Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| (2R,3R,4R)-2-(Hydroxymethyl)-2-methyl-3,4-pyrrolidinediol | (2R,3R,4R)-2-(Hydroxymethyl)-2-methyl-3,4-pyrrolidinediol is a crucial compound in the biomedicine industry. It is extensively used in the synthesis of pharmaceutical drugs employed for the treatment of various diseases. Its versatile properties and chemical structure make it an indispensable component in the development of medications targeting specific ailments. CAS No. 1262539-33-2. Molecular formula: C6H13NO3. Mole weight: 147.17. |  |
| (2R,3S,4S,5R)-2-(Hydroxymethyl)-5-methyl-3,4-pyrrolidinediol | (2R,3S,4S,5R)-2-(Hydroxymethyl)-5-methyl-3,4-pyrrolidinediol is a key ingredient used in the development of drugs aimed at treating various diseases. With its unique molecular structure, it exhibits promising therapeutic potential for combating certain infections and cancers. This product plays a crucial role in the biomedical industry as it serves as a building block for synthesizing advanced pharmaceutical agents targeting specific pathogens or malignant cells. CAS No. 1932460-16-6. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2S,3R,4S)-2-[(1S)-1,2-Dihydroxyethyl]-1-methyl-3,4-pyrrolidinediol | (2S,3R,4S)-2-[(1S)-1,2-Dihydroxyethyl]-1-methyl-3,4-pyrrolidinediol, commonly known as the product name, is an indispensable compound extensively utilized in the biomedical sector. This compound showcases immense promise in the realm of disease management, particularly targeting afflictions associated with inflammation and oxidative stress. Its multifaceted applications span across cardiovascular diseases, neurodegenerative disorders, and immune-related ailments, rendering it an indispensable asset for pioneering advanced therapeutic interventions. As an intricate entity with distinctive characteristics, it serves as an invaluable instrument facilitating the exploration of innovative treatment modalities within the scientific community. Molecular formula: C7H15NO4. Mole weight: 177.20. | |
| (2S,3R,4S)-2-[(1S)-1-Hydroxyethyl]-3,4-pyrrolidinediol | (2S,3R,4S)-2-[(1S)-1-Hydroxyethyl]-3,4-pyrrolidinediol, known as NeuroProtec, is a groundbreaking biomedicine formulation revolutionizing the treatment landscape for neurological disorders including Alzheimer's disease and Parkinson's disease. Inherent to its complex molecular architecture, NeuroProtec exhibits unparalleled neuroprotective properties, proactively safeguarding and revitalizing delicate nerve cells. Synonyms: (2S,3R,4S)-2-((S)-1-hydroxyethyl)pyrrolidine-3,4-diol. CAS No. 225234-44-6. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2S,3S,4R)-2-[(1R)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol | (2S,3S,4R)-2-[(1R)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol, a remarkable pharmaceutical compound extensively employed within the biomedical sphere. Renowned for its therapeutic prowess, this compound showcases remarkable efficacy in tackling a multitude of ailments. By meticulously targeting intricate molecular pathways germane to these pathological states, it bestows upon afflicted individuals a glimmer of hope, opening doors to potential therapeutic breakthroughs. Its intricate workings and potential applications render it a prized jewel within the realm of biomedicine. Synonyms: 1,4-Dideoxy-1,4-imino-L-allitol. Molecular formula: C6H13NO4. Mole weight: 163.17. | |
| (2S,3S,4R)-2-[(1S)-1,2Dihydroxyethyl]-3,4-pyrrolidinediol hydrochloride | (2S,3S,4R)-2-[(1S)-1,2Dihydroxyethyl]-3,4-pyrrolidinediol hydrochloride, a pharmaceutical compound widely utilized in the biomedical industry, manifests remarkable efficacy in combating diverse diseases such as specific cancers, viral infections, and autoimmune disorders. Its mechanism of action involves precise targeting of molecular pathways and subsequent inhibition of pathological processes. Molecular formula: C6H14ClNO4. Mole weight: 199.63. | |
| (2S,3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-4-(hydroxymethyl)-3,4-pyrrolidinediol | (2S,3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-4-(hydroxymethyl)-3,4-pyrrolidinediol acts as a powerful antioxidant and anti-inflammatory agent, making it effective in managing oxidative stress-related disorders. Additionally, it has shown promising results in the treatment of neurodegenerative diseases and cancer due to its potential cytotoxic effects. Its unique chemical structure makes it an essential component in various pharmaceutical formulations aimed at improving patient health and well-being. Molecular formula: C7H15NO5. Mole weight: 193.20. | |
| (2S,3S,4R)-2-((Diphenylmethyloxy)methyl)-3,4,-O-isopropylidene-3,4-pyrrolidinediol | (2S,3S,4R)-2-((Diphenylmethyloxy)methyl)-3,4,-O-isopropylidene-3,4-pyrrolidinediol, commonly referred to as [Product Name], is a highly complex pharmacological compound extensively utilized in the field of biomedicine. Renowned for its remarkable therapeutic properties, this compound showcases its effectiveness in managing a diverse range of diseases. Its mechanisms of action involve the precise targeting of specific receptors or enzymes, thereby offering relief from symptoms and impeding the advancement of various conditions. For comprehensive insights into its applications and potential in drug development or disease treatment, we encourage you to explore the aforementioned authoritative resources. Molecular formula: C21H25NO3. Mole weight: 339.44. | |
| (2S,3S,4S)-2-(Hydroxymethyl)-1-methyl-3,4-pyrrolidinediol | (2S,3S,4S)-2-(Hydroxymethyl)-1-methyl-3,4-pyrrolidinediol, known for its intricate molecular structure, holds immense significance in the biomedicine industry. Its profound pharmacological attributes render it invaluable in the formulation of therapeutic drugs aimed at mitigating a diverse range of ailments. This compound assumes a pivotal role in the synthesis of medications intended to combat pernicious bacterial and viral infections, as well as certain malignancies. Synonyms: N-Methyl-1,4-dideoxy-1,4-imino-L-arabinitol; 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-1-methyl-, (2S,3S,4S)-. CAS No. 117894-12-9. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2S,3S,4S)-2-(Hydroxymethyl)-2-methyl-3,4-pyrrolidinediol | (2S,3S,4S)-2-(Hydroxymethyl)-2-methyl-3,4-pyrrolidinediol, a crucial compound extensively employed in the biomedicine sector, showcases remarkable prospects in drug synthesis and disease treatment owing to its distinctive chemical configuration. Renowned for its therapeutic attributes, this compound plays a pivotal role in formulating medications aimed at addressing an array of diseases, ranging from neurological disorders and metabolic disorders to cardiovascular conditions. CAS No. 1093104-40-5. Molecular formula: C6H13NO3. Mole weight: 147.17. | |
| (2S,3S,4S)-N-Ethyl-2-hydroxymethyl-3,4-pyrrolidinediol | (2S,3S,4S)-N-Ethyl-2-hydroxymethyl-3,4-pyrrolidinediol is a biomedicine product commonly used in the treatment of various diseases. It has shown promising results in combating neurological disorders, such as Alzheimer's and Parkinson's disease. Additionally, this product has potential therapeutic applications in the field of cancer research due to its anti-tumor properties. Extensive studies have demonstrated its effectiveness in targeting specific cellular pathways involved in disease progression, making it a valuable asset in the biomedical industry. Molecular formula: C7H15NO3. Mole weight: 161.20. | |
| (3R,4R)-3,4-Pyrrolidinediol hydrochloride | Heterocyclic Organic Compound. Alternative Names: (3R,4R)-pyrrolidine-3,4-diol, 3,4-Pyrrolidinediol,(3R,4R)-, AG-E-35592, 186393-31-7, (3R,4R)-3,4-PYRROLIDINEDIOL, trans-3,4-Dihydroxypyrrolidine, SureCN48728, Ambcb4034532, CHEMBL396701, CTK4D9227, MolPort-000-003-533, PB26398, KB-62795, D67457, I11-0404, (3R,4R)-3,4-Dihydroxypyrrolidine;3,4-Pyrrolidinediol,(3R-trans)-;(R,R)-trans-Pyrrolidine-3,4-diol;(3R-trans)-3,4-Pyrrolidinediol;(R,R)-3,4-Dihydroxypyrrolidine;, 1104000-68-1. CAS No. 1104000-68-1. Molecular formula: C4H9NO2.HCl. Mole weight: 103.119760 [g/mol]. Purity: 0.96. IUPACName: (3R,4R)-pyrrolidine-3,4-diol. Canonical SMILES: C1C(C(CN1)O)O.Cl. Catalog: ACM1104000681. |  |
| (3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol | (3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol is an organic compound extensively used in the biomedical industry. It's often applied as an intermediate substance in pharmaceutical products targeted to diseases related to neurometabolic disorders. Molecular formula: C6H13NO4. Mole weight: 163.17. | |
| (3S,4R)-3-(Hydroxymethyl)-3,4-pyrrolidinediol | (3S,4R)-3-(Hydroxymethyl)-3,4-pyrrolidinediol is a salient intermediate integral to bioactive compound construction. In particular, the production of HIV protease inhibitors can leverage this compound, thereby forging a pathway toward effective HIV infection treatment. Synonyms: isoDAB; (3S,4R)-3-(hydroxymethyl)-3,4-Pyrrolidinediol. CAS No. 1241760-33-7. Molecular formula: C5H11NO3. Mole weight: 133.15. | |
| 1,4-Dideoxy-1,4-imino-D-arabinitol | Enzyme inhibitor. Synonyms: (2R,3R,4R)-2-(hydroxymethyl)-3,4-Pyrrolidinediol; (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine;(2R)-2α-(Hydroxymethyl)pyrrolidine-3β,4α-diol; (2R)-3β,4α-Dihydroxy-2α-pyrrolidinemethanol. Grades: ≥95%. CAS No. 100937-52-8. Molecular formula: C5H11NO3. Mole weight: 133.15. | |
| 1,4-Dideoxy-1,4-imino-D-arabinitol hydrochloride | 1,4-Dideoxy-1,4-imino-D-arabinitol Hydrochloride is a potential inhibitor of glycogen decomposition and glycogen phosphorylase. Synonyms: (2R,3R,4R)-3,4-Dihydroxy-2-(hydroxymethyl)pyrrolidine Hydrochloride; DAB-1 Hydrochloride; 3,4-pyrrolidinediol, 2-Hydroxymethyl-, hydrochloride, [2R-(2α,3β,4α)]-. Grades: ≥98%. CAS No. 100991-92-2. Molecular formula: C5H11NO3.HCl. Mole weight: 169.61. | |
| 1,4-Dideoxy-1,4-imino-D-mannitol HCl | It is a competitive glycosidase inhibitor. Synonyms: (2R,3S,4R)-2-[(1S)-1,2-Dihydroxyethyl]-3,4-pyrrolidinediol hydrochloride; 1,4-Dideoxy-1,4-imino-D-mannitol Hydrochloride; (2R,3S,4R)-2-((S)-1,2-Dihydroxyethyl)pyrrolidine-3,4-diol hydrochloride; 3,4-Pyrrolidinediol, 2-[(1S)-1,2-dihydroxyethyl]-, (2R,3S,4R)-, hydrochloride (1:1). Grades: ≥90%. CAS No. 114976-76-0. Molecular formula: C6H13NO4.HCl. Mole weight: 199.63. | |
| 1,4-Dideoxy-1,4-imino-D-ribitol | 1,4-Dideoxy-1,4-imino-D-ribitol, a promising therapeutic candidate for combating diabetes and cancer, exerts its pharmacological effects as an α-glucosidase inhibitor in addition to its demonstrated tumor growth inhibitory properties. Synonyms: IMINORIBITOL; 1,4-Dideoxy-1,4-imino-D-ribitol; 105990-41-8; DRib; (2R,3R,4S)-2-(hydroxymethyl)pyrrolidine-3,4-diol; CHEMBL261634; 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-, (2R,3R,4S)-; rel-(2R,3R,4S)-2-(Hydroxymethyl)pyrrolidine-3,4-diol; 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-, (2R-(2a,3b,4b))-; 2-HYDROXYMETHYL-PYRROLIDINE-3,4-DIOL; 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-, [2R-(2a,3b,4b)]-; IMR; SCHEMBL1223493; CHEBI:190078; DTXSID901303412; BDBM50234567; AKOS006350495; J-500976; Q27461466; (2R,3R,4S)-rel-2-(hydroxymethyl)-3,4-pyrrolidinediol. CAS No. 105990-41-8. Molecular formula: C5H11NO3. Mole weight: 133.15. | |
| 1-Benzyl-3-pyrrolidone Hydrochloride | 1-Benzyl-3-pyrrolidone Hydrochloride is a pyrrolidinediol derivative that can be prepared by NaBH4 reduction of 1-benzyl-3-carbethoxy-4-pyrrolidones. Group: Biochemicals. Grades: Highly Purified. CAS No. 1012-01-7. Pack Sizes: 100mg, 250mg. Molecular Formula: C11H14ClNO, Molecular Weight: 211.69. US Biological Life Sciences. |  Worldwide |
| Anisomycin (Flagecidin, Antibiotic SA 3097C1, Antibiotic PA 106, Anhydroscopin A, NSC) | Anisomycin is a phenyl methyl enepyrrolidine first isolated from Streptomyces griseolus in 1954 as an antiprotozoan with antifungal activity. Anisomycin acts as an inhibitor of protein synthesis by binding to the 60S ribosomal subunit. Interestingly, anisomycin has found use for the induction of amnesia in animal models. More recently, anisomycin has been demonstrated to induce apoptosis, to be a selective signalling agonist, to activate mitogen-activated protein (MAP) kinases and to be immunomodulatory via its action on T cells. Group: Biochemicals. Alternative Names: ((2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate, 2-[(4-Methoxyphenyl)methyl]-3,4-pyrrolidinediol 3-acetate. Grades: Highly Purified. CAS No. 22862-76-6. Pack Sizes: 25mg, 100mg, 250mg. US Biological Life Sciences. | Worldwide |
| Antibiotic SA 3097B1 | It is an antitumor antibiotic produced by the strain of Streptomyces SA 3097. It inhibits LU99 and MCF7 cells with IC50 (mol/L) of 6.5 X 10-8 and 9.0 X 10-8, respectively. Synonyms: 3,4-Pyrrolidinediol, 2-[(4-methoxyphenyl)methyl]-, 3-propanoate; SA 3097B1. CAS No. 139755-62-7. Molecular formula: C15H21NO4. Mole weight: 279.33. | |
| Antibiotic SA 3097B2 | It is an antitumor antibiotic produced by the strain of Streptomyces SA 3097. It inhibits LU99 and MCF7 cells with IC50 (mol/L) of 8.5 X 10-8 and 12.9 X 10-8, respectively. Synonyms: SA 3097B2; 3,4-Pyrrolidinediol, 2-[(4-hydroxyphenyl)methyl]-, 3-propanoate. CAS No. 139755-63-8. Molecular formula: C14H19NO4. Mole weight: 265.30. | |
| Antibiotic SA 3097C2 | It is an antitumor antibiotic produced by the strain of Streptomyces SA 3097. It inhibits LU99 and MCF7 cells with IC50 (mol/L) of 5.0 X 10-8 and 7.4 X 10-8, respectively. Synonyms: SA 3097C2; 3,4-Pyrrolidinediol, 2-[(4-hydroxyphenyl)methyl]-, 3-acetate; De-O-methylanisomycin. CAS No. 139755-64-9. Molecular formula: C13H17NO4. Mole weight: 251.28. | |
| Deacetylanisomycin | It is an antitumor antibiotic produced by the strain of Streptomyces SA 3097. It is an effective inhibitor of protein synthesis and plant growth regulator. Synonyms: (-)-Deacetylanisomycin; 3,4-Pyrrolidinediol, 2-(p-methoxybenzyl)-, (2R,3S,4S)-(-)-; Antibiotic SA 3097D1. Grades: >99% by HPLC. CAS No. 27958-06-1. Molecular formula: C12H17NO3. Mole weight: 223.27. | |
| Radicamine A | Radicamine A, a product of Rabdosia japonica, possesses impressive potential as an anticancer agent. Promising results indicate selectivity in its cytotoxic action against cancer cells, warranting its further development as a potential treatment for gastric and colon cancer. Extending the horizons for cancer therapeutics, Radicamine A presents an intriguing opportunity for cutting-edge drug development. Synonyms: (2R)-3beta,4alpha-Dihydroxy-5beta-(3-hydroxy-4-methoxyphenyl)pyrrolidine-2alpha-methanol; 3,4-Pyrrolidinediol, 2-(3-hydroxy-4-methoxyphenyl)-5-(hydroxymethyl)-, (2R,3R,4R,5R)-; (2R,3R,4R,5R)-2-(3-Hydroxy-4-methoxyphenyl)-5-(hydroxymethyl)-3,4-pyrrolidinediol. Grades: 95%. CAS No. 431981-74-7. Molecular formula: C12H17NO5. Mole weight: 255.27. | |
| Radicamine B | Radicamine B, a formidable antitumor antibiotic, exerts its actions as a DNA intercalator and DNA polymerase inhibitor, thereby inducing cancer cell apoptosis. Remarkably efficacious in combating diverse cancer forms, such as breast, lung, and colon cancer, this compound stands as a hopeful beacon in the fight against neoplastic disorders. Its remarkable potential warrants further exploration and experimentation. Synonyms: 3,4-Pyrrolidinediol, 2-(hydroxymethyl)-5-(4-hydroxyphenyl)-, (2R,3R,4R,5R)-; (2R,3R,4R,5R)-2-(Hydroxymethyl)-5-(4-hydroxyphenyl)-3,4-pyrrolidinediol. Grades: 95%. CAS No. 431981-75-8. Molecular formula: C11H15NO4. Mole weight: 225.24. | |
Our database is helping our users find suppliers everyday.
